- $11.61bn
- $11.25bn
- $1.19bn
Annual income statement for Penumbra, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 560 | 748 | 847 | 1,059 | 1,195 |
| Cost of Revenue | |||||
| Gross Profit | 338 | 475 | 535 | 683 | 755 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 599 | 755 | 841 | 985 | 1,185 |
| Operating Profit | -38.9 | -7.5 | 6.08 | 73.6 | 9.28 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -38 | -10.5 | 3.89 | 79.7 | 20.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -19.3 | 2.62 | -2 | 91 | 14 |
| Minority Interest | |||||
| Equity in Affiliates | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -15.7 | 5.28 | -2 | 91 | 14 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -15.7 | 5.28 | -2 | 91 | 14 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.07 | 0.582 | -0.053 | 2.78 | 1.76 |